Mathematical modeling of variables involved in dissolution testing

Journal of Pharmaceutical Sciences

Volumn 100, Issue 11, 2011, Pages 4934-4942

  Gao, Zongming ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Dissolution rate; Dissolution testing; In vitro models; Mathematical model; Variables

Indexed keywords

PREDNISONE;

ARTICLE; DISSOLUTION TESTING; DRUG INDUSTRY; DRUG SOLUBILITY; HIGUCHI EQUATION; KORSMEYER PEPPAS EQUATION; MATHEMATICAL MODEL; NOYES WHITNEY EQUATION; PHARMACEUTICAL ENGINEERING; QUALITY CONTROL; TABLET DISINTEGRATION; WEIBULL EQUATION;

EID: 80053241913     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22673     Document Type: Article

References (28)

1. Dokoumetzidis A, Macheras P. 2006. A century of dissolution research: From Noyes and Whitney to the Biopharmaceutics Classification System. Int J Pharm 321:1-11.
2. Siewert M, Dressman J, Brown CK, Shah VP. 2003. FIP/AAPS guidelines to dissolution/in vitro release testing of novel/special dosage forms. AAPS PharmSciTech 4(1):article 7.
3. McCormick TJ. 1995. Industry perspective on dissolution apparatus calibration. Dissolution Technol 2(4):12-15.
4. Skoug JW. 1994. Calibration of dissolution rate apparatuses: A user's perspective. Dissolution Technol 1(2):3-5.
5. Cox DC, Wells CE, Furman WB, Savage TS, King AC. 1982. System error associated with apparatus 2 of the USP dissolution test II: Effects of deviations in vessel curvature from that of a sphere. J Pharm Sci 71:395-399.
6. Cox DC, Furman WB. 1984. Collaborative study of the USP dissolution test for prednisone tablets with apparatus 2. J Pharm Sci 73:670-676.
7. Siewert M, Weinandy L, Whiteman D, Judkins C. 2002. Typical variability and evaluation of sources of variability in drug dissolution testing. Eur J Pharm Sci 53:9-14.
8. Qureshi SA, Shabnam J. 2001. Cause of high variability in drug dissolution testing and its impact on setting tolerances. Eur J Pharm Sci 12:271-276.
9. Gao Z, Moore TW, Doub WH, Westenberger BJ, Buhse LF. 2006. Effects of deaeration methods on dissolution testing in aqueous media: A study using a total dissolved gas pressure meter. J Pharm Sci 95:1606-1613.
10. Gao Z, Moore TW, Smith AP, Doub WH, Westenberger BJ. 2007. Studies of variability in dissolution testing with USP apparatus 2. J Pharm Sci 96:1794-1801.
11. Gao Z, Ahadi S, Moore TW, Doub WH, Westenberger BJ, Buhse LF. 2011. Vessel geometric irregularity and its effect on dissolution results. J Pharm Sci 100:1091-1101.
12. Healy AM, McCarthy LG, Gallagher KM, Corrigan OI. 2002. Sensitivity of dissolution rate to location in the paddle dissolution apparatus. J Pharm Pharmacol 54:441-444.
13. Kukura J. 2004. Shear distribution and variability in the USP apparatus 2 under turbulent conditions. Int J Pharm 279:9-17.
14. Baxter JL, Kukura J, Muzzio FJ. 2005. Hydrodynamics-induced variability in the USP apparatus II. Int J Pharm 292:17-28.
15. McCarthy LG, Bradley G, Sexton JC, Corrigan OI, Healy AM. 2004. Computational fluid dynamics modeling of the paddle dissolution apparatus: Agitation rate, mixing patterns, and fluid velocities. AAPS PharmSciTech 5:article 31.
16. McCarthy LG, Kosiol C, Healy AM, Bradley G, Sexton JC, Corrigan OI. 2003. Simulating the hydrodynamic conditions in the USP paddle dissolution apparatus. AAPS PharmSciTech 4:article 22.
17. Gao Z, Moore TW, Doub WH. 2008. Vibration effects on dissolution tests with USP apparatuses 1 and 2. J Pharm Sci 97:3335-3343.
18. Costa P, Sousa Lobo JM. 2001. Influence of dissolution medium agitation on release profiles of sustained-release tablets. Drug Dev Ind Pharm 27:811-817.
19. Rinaki E, Valsami G, Macheras P. 2003. The power law can describe the "entire" drug release curve from HPMC-based matrix tablets: A hypothesis. Int J Pharm 255:199-207.
20. Kervinen L, Yliruusi J. 1993. Modelling S-shape dissolution curves. Int J Pharm 92:115-122.
21. Costa P. 2001. An alternative method to the evaluation of similarity factor in dissolution testing. Int J Pharm 220:77-83.
22. Giovagnoli S, Blasi P, Ricci M, Schoubben A, Perioli L, Rossi C. 2008. Physicochemical characterization and release mechanism of a novel prednisone biodegradable microsphere formulation. J Pharm Sci 97: 303-317.
23. Higuchi T. 1963. Mechanism of sustained-action medication: Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci 52:1145-1149.
24. Nikolic L, Djuric Z, Jovanovic M. 1991. Influence of in vitro test conditions on release of aspirin from commercial tablets. J Pharm Sci 81:386-391.
25. Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. 1983. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm 15:25-35.
26. Papdopoulou V, Kosmidis K, Vlachou M, Macheras P. 2006. On the use of the Weibull function for the discernment of drug release mechanisms. Int J Pharm 309:44-50.
27. Langenbucher F. 1972. Linearization of dissolution rate curves by the Weibull distribution. J Pharm Pharmacol 24:979-981.
28. Vogt M, Derendorf H, Kra Mer J, Junginger HE, Midha KK, Shah VP, Stavchansky S, Dressman JB, Barends DM. 2007. Biowaiver monographs for immediate release solid oral dosage forms: Prednisone. J Pharm Sci 96:1-10.